Measurement properties of quality-of-life outcome measures for children and adults with eczema: An updated systematic review
- PMID: 31505076
- DOI: 10.1111/pai.13120
Measurement properties of quality-of-life outcome measures for children and adults with eczema: An updated systematic review
Abstract
Objective: The aim of this updated systematic review was to systematically assess the measurement properties of previously discussed and new quality-of-life patient-reported outcome measures (PROMs) in children and adults with eczema using the new COSMIN guideline.
Methods: A systematic literature search was conducted in PubMed and EMBASE. Eligible studies reported on measurement properties of quality-of-life PROMs for children and adults with eczema. The methodological quality of selected already known PROMs and new evidence identified through the literature search was assessed with the COSMIN Risk of Bias checklist. The adequacy of included PROMs was judged with updated quality criteria, and the quality of evidence of the summarized results was graded. Finally, PROMs were placed in a recommendation category (A-C).
Results: In total, 133 measurement properties of nine different PROMs were assessed. No PROM could be placed in category A due to a lack of validation studies. Only the DLQI fulfilled the criteria for category C and therefore should not be recommended for use. All other PROMs were placed in category B, that is, they still have the opportunity to be recommended, but need further validation.
Conclusions: Currently, no PROM for quality of life can be recommended for use in children and adults with eczema. Further validation is needed. The DLQI cannot be recommended for future use.
Keywords: atopic dermatitis; eczema; measurement properties; patient-reported outcome measures; quality of life.
© 2019 The Authors. Pediatric Allergy and Immunology published by John Wiley & Sons Ltd.
Similar articles
-
Evaluating patient-reported outcome measures (PROMs) for bladder cancer: a systematic review using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist.BJU Int. 2018 Nov;122(5):760-773. doi: 10.1111/bju.14368. Epub 2018 Jun 8. BJU Int. 2018. PMID: 29726085 Free PMC article.
-
COSMIN guideline for systematic reviews of patient-reported outcome measures version 2.0.Qual Life Res. 2024 Nov;33(11):2929-2939. doi: 10.1007/s11136-024-03761-6. Epub 2024 Aug 28. Qual Life Res. 2024. PMID: 39198348 Free PMC article.
-
Measurement Properties of Patient-Reported Outcome Measures for Medication Adherence in Cardiovascular Disease: A COSMIN Systematic Review.Clin Drug Investig. 2022 Nov;42(11):879-908. doi: 10.1007/s40261-022-01199-7. Epub 2022 Oct 1. Clin Drug Investig. 2022. PMID: 36180813 Free PMC article.
-
Measurement properties of patient-reported outcome measures (PROMs) in patients with hyperhidrosis: protocol for a systematic review.Syst Rev. 2021 Jun 2;10(1):163. doi: 10.1186/s13643-021-01701-w. Syst Rev. 2021. PMID: 34078465 Free PMC article.
-
Use of Patient-Reported Outcome Measures to Assess Outpatient Postpartum Recovery: A Systematic Review.JAMA Netw Open. 2021 May 3;4(5):e2111600. doi: 10.1001/jamanetworkopen.2021.11600. JAMA Netw Open. 2021. PMID: 34042993 Free PMC article.
Cited by
-
Patient-Reported Outcome Measures in Dermatology: A Systematic Review.Acta Derm Venereol. 2021 Sep 28;101(9):adv00559. doi: 10.2340/00015555-3884. Acta Derm Venereol. 2021. PMID: 34263330 Free PMC article.
-
Current measures are not sufficient: an interview-based qualitative assessment of quality of life in cutaneous T-cell lymphoma.Br J Dermatol. 2021 Feb;184(2):310-318. doi: 10.1111/bjd.19298. Epub 2020 Aug 2. Br J Dermatol. 2021. PMID: 32510571 Free PMC article.
-
Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis.Eur J Health Econ. 2023 Feb;24(1):139-152. doi: 10.1007/s10198-022-01460-y. Epub 2022 Apr 12. Eur J Health Econ. 2023. PMID: 35412162 Free PMC article.
-
Responsiveness of quality of life measures in children with peripheral vascular malformations: The OVAMA project.JPRAS Open. 2020 Nov 30;27:70-79. doi: 10.1016/j.jpra.2020.11.013. eCollection 2021 Mar. JPRAS Open. 2020. PMID: 33364290 Free PMC article.
-
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting.Br J Dermatol. 2021 Jul;185(1):139-146. doi: 10.1111/bjd.19751. Epub 2021 Feb 8. Br J Dermatol. 2021. PMID: 33393074 Free PMC article.
References
REFERENCES
-
- Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351.
-
- Drucker AM, Wang AR, Li WQ, Sevetson E, Block JK, Qureshi AA. The burden of atopic dermatitis: summary of a report for the National Eczema Association. J Invest Dermatol. 2017;137(1):26-30.
-
- Schmitt J, Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting. Allergy. 2012;67(9):1111-1117.
-
- Marshall S, Haywood K, Fitzpatrick R. Impact of patient-reported outcome measures on routine practice: a structured review. J Eval Clin Pract. 2006;12(5):559-568.
-
- Heinl D, Prinsen CA, Deckert S, et al. Measurement properties of adult quality-of-life measurement instruments for eczema: a systematic review. Allergy. 2016;71(3):358-370.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical